DJO Global narrows its Q3 losses
DJO Global posts improved Q3 results, narrowing its losses and increasing its sales.
DJO Global made some progress during its 3rd quarter, reporting in the red but narrowing its losses by 12.4% along the way.
The San Diego, Calif.-based medical device company posted $22.6 million in net losses on sales of $274 million for the 3 months ended Sept. 29. That compared with a net loss of $25.8 million, on sales of $263 million during the same period last year.